BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Endocrine gland cancer AND POLE, POLE1, 5426, FLJ21434, DKFZp434F222, ENSG00000177084 AND Prognosis
31 results:

  • 1. Comprehensive analysis of clinicopathologic and sonographic features in thyroid cancer with skip lymph node metastasis: establish and assessment of a prediction nomogram.
    Jiwang L; Jinghui B; Fengqin F; Tao Y; Yuejiao Z
    Braz J Otorhinolaryngol; 2023; 89(5):101301. PubMed ID: 37579569
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Identification of BRAF, CCND1, and MYC mutations in a patient with multiple primary malignant tumors: a case report and review of the literature.
    Liu Z; Jin C; Zhang Y; Jiang Y; Wang J; Zheng L
    World J Surg Oncol; 2023 May; 21(1):158. PubMed ID: 37221610
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Metastatic Thyroid Carcinoma to the Kidneys Presenting Initially as Bilateral Renal Masses: A Rare Case Report and Literature Review.
    Youssef B; Hanna K; Bowman A; Ardor GD; Alhaj AM; Nassar A
    Int J Surg Pathol; 2023 Aug; 31(5):795-800. PubMed ID: 36437643
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Diagnostic accuracy of mutational analysis along the Müllerian tract to detect ovarian cancer.
    van Bommel MHD; Pijnenborg JMA; van der Putten LJM; Bulten J; Snijders MPLM; Küsters-Vandevelde HVN; Sweegers S; Vos MC; Ligtenberg MJL; Eijkelenboom A; de Hullu JA; Reijnen C
    Int J Gynecol Cancer; 2022 Dec; 32(12):1568-1575. PubMed ID: 36384753
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. TCGA molecular classification in endometriosis-associated ovarian carcinomas: Novel data on clear cell carcinoma.
    Similä-Maarala J; Soovares P; Pasanen A; Ahvenainen T; Vahteristo P; Bützow R; Lassus H
    Gynecol Oncol; 2022 Jun; 165(3):577-584. PubMed ID: 35370008
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. The prognosis of Skip Metastasis in Papillary Thyroid Microcarcinoma Is Better Than That of Continuous Metastasis.
    Weng HY; Yan T; Qiu WW; Fan YB; Yang ZL
    J Clin Endocrinol Metab; 2022 May; 107(6):1589-1598. PubMed ID: 35213704
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Endometrial cancer Molecular Risk Stratification is Equally Prognostic for Endometrioid Ovarian Carcinoma.
    Krämer P; Talhouk A; Brett MA; Chiu DS; Cairns ES; Scheunhage DA; Hammond RFL; Farnell D; Nazeran TM; Grube M; Xia Z; Senz J; Leung S; Feil L; Pasternak J; Dixon K; Hartkopf A; Krämer B; Brucker S; Heitz F; du Bois A; Harter P; Kommoss FKF; Sinn HP; Heublein S; Kommoss F; Vollert HW; Manchanda R; de Kroon CD; Nijman HW; de Bruyn M; Thompson EF; Bashashati A; McAlpine JN; Singh N; Tinker AV; Staebler A; Bosse T; Kommoss S; Köbel M; Anglesio MS
    Clin Cancer Res; 2020 Oct; 26(20):5400-5410. PubMed ID: 32737030
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Medullary Pancreatic Carcinoma Due to Somatic pole Mutation: A Distinctive Pancreatic Carcinoma With Marked Long-Term Survival.
    Kryklyva V; Ter Linden E; Kroeze LI; de Voer RM; van der Kolk BM; Stommel MWJ; Hermans JJ; Luchini C; Wood LD; Hruban RH; Nagtegaal ID; Ligtenberg MJL; Brosens LAA
    Pancreas; 2020 Aug; 49(7):999-1003. PubMed ID: 32658072
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Molecular Heterogeneity of Endometrioid Ovarian Carcinoma: An Analysis of 166 Cases Using the Endometrial cancer Subrogate Molecular Classification.
    Leskela S; Romero I; Rosa-Rosa JM; Caniego-Casas T; Cristobal E; Pérez-Mies B; Gutierrez-Pecharroman A; Santón A; Ojeda B; López-Reig R; Palacios-Berraquero ML; Andrada E; Montes S; Pastor F; Gomez MC; López-Guerrero JA; Poveda A; Palacios J
    Am J Surg Pathol; 2020 Jul; 44(7):982-990. PubMed ID: 32384322
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Molecular profiling identifies synchronous endometrial and ovarian cancers as metastatic endometrial cancer with favorable clinical outcome.
    Reijnen C; Küsters-Vandevelde HVN; Ligtenberg MJL; Bulten J; Oosterwegel M; Snijders MPLM; Sweegers S; de Hullu JA; Vos MC; van der Wurff AAM; van Altena AM; Eijkelenboom A; Pijnenborg JMA
    Int J Cancer; 2020 Jul; 147(2):478-489. PubMed ID: 32022266
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. ACTH-dependent Hypercortisolemia in a Patient with a Pituitary Microadenoma and an Atypical Carcinoid Tumour of the Thymus.
    Baranowska-Jurkun A; Szychlińska M; Matuszewski W; Modzelewski R; Bandurska-Stankiewicz E
    Medicina (Kaunas); 2019 Nov; 55(12):. PubMed ID: 31783507
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Identification of driver genes and key pathways of prolactinoma predicts the therapeutic effect of genipin.
    Zhong S; Wu B; Wang X; Sun D; Liu D; Jiang S; Ge J; Zhang Y; Liu X; Zhou X; Jin R; Chen Y
    Mol Med Rep; 2019 Sep; 20(3):2712-2724. PubMed ID: 31322266
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Skip metastases to lateral cervical lymph nodes in differentiated thyroid cancer: a systematic review.
    Attard A; Paladino NC; Lo Monte AI; Falco N; Melfa G; Rotolo G; Rizzuto S; Gulotta E; Salamone G; Bonventre S; Scerrino G; Cocorullo G
    BMC Surg; 2019 Apr; 18(Suppl 1):112. PubMed ID: 31074393
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Diagnosis and management of a recurrent polymerase-epsilon (pole)-mutated endometrial cancer.
    Veneris JT; Lee EK; Goebel EA; Nucci MR; Lindeman N; Horowitz NS; Lee L; Raut CP; Crotzer D; Matulonis U; Konstantinopoulos PA; Campos S
    Gynecol Oncol; 2019 Jun; 153(3):471-478. PubMed ID: 30935717
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. High frequency of pole mutations in synchronous endometrial and ovarian carcinoma.
    Ishikawa M; Nakayama K; Nakamura K; Ono R; Yamashita H; Ishibashi T; Minamoto T; Iida K; Razia S; Ishikawa N; Kyo S
    Hum Pathol; 2019 Mar; 85():92-100. PubMed ID: 30448219
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. pole gene hotspot mutations in advanced pancreatic cancer.
    Guenther M; Veninga V; Kumbrink J; Haas M; Westphalen CB; Kruger S; Heinemann V; Kirchner T; Boeck S; Jung A; Ormanns S
    J Cancer Res Clin Oncol; 2018 Nov; 144(11):2161-2166. PubMed ID: 30194485
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Clinical analysis of cervical lymph node metastasis risk factors in patients with papillary thyroid microcarcinoma.
    Luo Y; Zhao Y; Chen K; Shen J; Shi J; Lu S; Lei J; Li Z; Luo D
    J Endocrinol Invest; 2019 Feb; 42(2):227-236. PubMed ID: 29876836
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Lateral lymph node metastasis in papillary thyroid carcinoma: A systematic review and meta-analysis for prevalence, risk factors, and location.
    So YK; Kim MJ; Kim S; Son YI
    Int J Surg; 2018 Feb; 50():94-103. PubMed ID: 29329789
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Molecular-based classification algorithm for endometrial carcinoma categorizes ovarian endometrioid carcinoma into prognostically significant groups.
    Parra-Herran C; Lerner-Ellis J; Xu B; Khalouei S; Bassiouny D; Cesari M; Ismiil N; Nofech-Mozes S
    Mod Pathol; 2017 Dec; 30(12):1748-1759. PubMed ID: 28776572
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. PTK6 activation at the membrane regulates epithelial-mesenchymal transition in prostate cancer.
    Zheng Y; Wang Z; Bie W; Brauer PM; Perez White BE; Li J; Nogueira V; Raychaudhuri P; Hay N; Tonetti DA; Macias V; Kajdacsy-Balla A; Tyner AL
    Cancer Res; 2013 Sep; 73(17):5426-37. PubMed ID: 23856248
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.